Millennium Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-33,154
Closed -$647K 4406
2024
Q1
$647K Buy
33,154
+25,961
+361% +$506K ﹤0.01% 3181
2023
Q4
$149K Buy
+7,193
New +$149K ﹤0.01% 3623
2023
Q3
Sell
-41,210
Closed -$1.38M 4514
2023
Q2
$1.38M Sell
41,210
-21,652
-34% -$728K ﹤0.01% 2734
2023
Q1
$2.62M Buy
62,862
+7,765
+14% +$324K ﹤0.01% 2359
2022
Q4
$1.87M Sell
55,097
-106,428
-66% -$3.61M ﹤0.01% 2751
2022
Q3
$7.95M Buy
161,525
+118,093
+272% +$5.81M ﹤0.01% 1817
2022
Q2
$1.71M Sell
43,432
-17,838
-29% -$701K ﹤0.01% 3012
2022
Q1
$2.26M Buy
61,270
+26,244
+75% +$968K ﹤0.01% 2955
2021
Q4
$3.43M Buy
35,026
+22,883
+188% +$2.24M ﹤0.01% 2542
2021
Q3
$1.52M Sell
12,143
-30,022
-71% -$3.75M ﹤0.01% 3284
2021
Q2
$5.29M Buy
42,165
+4,787
+13% +$600K ﹤0.01% 2080
2021
Q1
$5.07M Buy
37,378
+16,177
+76% +$2.2M ﹤0.01% 2045
2020
Q4
$1.93M Sell
21,201
-32,101
-60% -$2.92M ﹤0.01% 2533
2020
Q3
$3.97K Sell
53,302
-4,672
-8% -$348 ﹤0.01% 1590
2020
Q2
$4.94M Sell
57,974
-27,861
-32% -$2.37M 0.01% 1408
2020
Q1
$6.21M Buy
85,835
+39,392
+85% +$2.85M 0.01% 925
2019
Q4
$3.32M Buy
46,443
+37,675
+430% +$2.69M ﹤0.01% 1813
2019
Q3
$460K Sell
8,768
-4,819
-35% -$253K ﹤0.01% 2733
2019
Q2
$730K Buy
+13,587
New +$730K ﹤0.01% 2541
2019
Q1
Sell
-350
Closed -$28K 3674
2018
Q4
$28K Sell
350
-3,979
-92% -$318K ﹤0.01% 3263
2018
Q3
$2.02M Buy
4,329
+347
+9% +$162K ﹤0.01% 2137
2018
Q2
$1.58M Buy
+3,982
New +$1.58M ﹤0.01% 2261
2018
Q1
Sell
-9,509
Closed -$2.8M 3706
2017
Q4
$2.8M Buy
9,509
+7,405
+352% +$2.18M ﹤0.01% 1934
2017
Q3
$1.15M Sell
2,104
-6,784
-76% -$3.71M ﹤0.01% 2232
2017
Q2
$5.3M Buy
8,888
+986
+12% +$588K 0.01% 1339
2017
Q1
$3.4M Buy
7,902
+3,835
+94% +$1.65M 0.01% 1537
2016
Q4
$2.09M Buy
+4,067
New +$2.09M ﹤0.01% 1705
2016
Q3
Sell
-852
Closed -$358K 3235
2016
Q2
$358K Buy
+852
New +$358K ﹤0.01% 2422